New knee shot aims to ease arthritis pain in veterans
NCT ID NCT07481474
First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times
Summary
This early-stage study tests a new anti-CD14 injection for knee osteoarthritis in 30 Veterans. The goal is to see if the shot is safe and feasible, and if it can reduce pain and improve function. Participants will receive either a low dose, high dose, or placebo injection and be followed for 4 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRITIS (KNEE OA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
Philadelphia, Pennsylvania, 19104-4551, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pain drug help you walk better with knee arthritis?
- Can a booklet boost knee surgery recovery?
- Can a simple pressure-sensing device beat foam rolling for knee arthritis pain?
- Breathing against resistance may ease knee arthritis pain
- Laser light could ease knee arthritis without drugs or surgery
- Resveratrol plus diet shows promise for knee OA in obese postmenopausal women